FGL1 and non-small cell lung carcinoma: In the current study, we found that knockdown of FGL1 led to clearly enhanced the expression of cleaved caspase 3 and cleaved PARP1, and overcame acquired resistance to gefitinib in NSCLC cells both in vitro and in vivo.